Search results
AstraZeneca confirms strong vaccine protection after US rift
AOL· 12 hours agoAstraZeneca insists that its COVID-19 vaccine is strongly effective even after counting additional...
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 1 day agoAstraZeneca AZN will report first-quarter 2024 results on Apr 25, before market open. In the last...
Analysts Set AstraZeneca PLC (NASDAQ:AZN) Price Target at $80.00
ETF DAILY NEWS· 14 hours agoShares of AstraZeneca PLC (NASDAQ:AZN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six brokerages that are currently covering the ...
ANGLE partners with AstraZeneca in groundbreaking oncology contract
Proactive Investors· 6 hours agoANGLE PLC (AIM:AGL, OTCQX:ANPCY) chief executive Andrew Newland joins Proactive's Stephen Gunnion...
ANGLE inks AstraZeneca deal to develop ground-breaking cancer assay
Proactive Investors· 9 hours agoANGLE PLC (AIM:AGL, OTCQX:ANPCY), the developer of liquid biopsy technologies, has partnered with ...
Angle Inks Assay Development Deal with AstraZeneca
GenomeWeb News· 2 hours agoCirculating tumor cell (CTC) assay developer Angle said Wednesday that it has signed a supplier agreement with AstraZeneca to develop and validate a method for the detection ...
With 85% ownership, AstraZeneca PLC (LON:AZN) boasts of strong institutional backing
Simply Wall St. via Yahoo Finance· 2 days agoKey Insights Given the large stake in the stock by institutions,AstraZeneca's stock price might be...
AstraZeneca: What The Market's Missing (NASDAQ:AZN)
Seeking Alpha· 8 hours agoAnalyst’s Disclosure: I/we have a beneficial long position in the shares of AZN either through stock ownership, options, or other derivatives. All...
Astrazeneca (AZN) Could Be a Great Choice
Zacks via Yahoo Finance· 6 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Astrazeneca (AZN) have what it...
Zacks Research Weighs in on AstraZeneca PLC’s Q2 2025 Earnings (NASDAQ:AZN)
ETF DAILY NEWS· 6 days agoAstraZeneca PLC (NASDAQ:AZN – Free Report) – Equities research analysts at Zacks Research cut their Q2 2025 EPS estimates for shares of AstraZeneca in a ...
